Moreover, we present a novel finding related to the ability of CCL5 to induced proliferation in LNCaP cells thank to the activation of STAT5 and the consequent increase of expression of cyclin D1, a pathway controlling cell growth in normal and prostate cancer cells. This evidence concerns the gene CCL5 and prostate carcinoma.